The Federal Trade Commission was a vocal critic of the proposed merger. Elizabeth Wilkins, director of the FTC Office of Policy Planning said in a statement that it is very good news that the proposed merger is not going to happen. Wilkins said, "The deal presented substantial risk of serious competitive and consumer harm in the form of higher healthcare costs, lower quality, reduced innovation, reduced access to care, and depressed wages for hospital employees."
